LCP-TACRO
DEAD

Serial Number

85952500

Owner

VELOXIS PHARMACEUTICALS A/S

Attorney

Bassam N. Ibrahim

Filing Date

Jun 6, 2013

Add to watchlist:

No watchlists yet
View on USPTO

LCP-TACRO Trademark

Serial Number: 85952500

LCP-TACRO is a trademark filed by VELOXIS PHARMACEUTICALS A/S on June 6, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

VELOXIS PHARMACEUTICALS A/S (27 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOLM , DK

Entity Type: 99

Trademark Details

Filing Date

June 6, 2013

Registration Date

Not Registered

Published for Opposition

April 1, 2014

Goods & Services

Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy and immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynaecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized pain

Medical services; medical testing services, namely, clinical testing; medical assistance services; medical and pharmaceutical consultation services

Scientific and technological services, namely, clinical testing and technology transfer services, as well as research and design in connection therewith, namely, within the medical, pharmaceutical, biotechnical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries; providing medical and scientific research information in the field of pharmaceuticals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 3, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 3, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2016 EXRA
SOU EXTENSION 5 GRANTED
Dec 7, 2016 EX5G
SOU EXTENSION 5 FILED
Nov 28, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 28, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2016 EXRA
SOU EXTENSION 4 GRANTED
Jun 8, 2016 EX4G
SOU EXTENSION 4 FILED
May 23, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
May 23, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2015 EXRA
SOU EXTENSION 3 GRANTED
Dec 22, 2015 EX3G
SOU EXTENSION 3 FILED
Nov 9, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 9, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2015 EXRA
SOU EXTENSION 2 GRANTED
Jun 19, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 19, 2015 AITU
SOU EXTENSION 2 FILED
May 21, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
May 21, 2015 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2015 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2014 EXRA
SOU EXTENSION 1 GRANTED
Sep 11, 2014 EX1G
SOU EXTENSION 1 FILED
Sep 11, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 11, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 27, 2014 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Apr 8, 2014 CHPB
ASSIGNED TO PETITION STAFF
Apr 7, 2014 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 2, 2014 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2014 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 25, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 22, 2013 GNRN
NON-FINAL ACTION E-MAILED
Oct 22, 2013 GNRT
NON-FINAL ACTION WRITTEN
Oct 22, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 1, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2013 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2013 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2013 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2013 DOCK
ASSIGNED TO EXAMINER
Jul 27, 2013 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 17, 2013 AMPX
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2013 NWOS
ASSIGNED TO LIE
Jun 13, 2013 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 12, 2013 PARI
NEW APPLICATION ENTERED
Jun 10, 2013 NWAP